糖化白蛋白与阿司匹林抵抗的关系

发布时间：2018-01-24 01:54

本文关键词： 糖化白蛋白阿司匹林抵抗脑梗死糖尿病综述　出处：《中国脑血管病杂志》2017年09期 　论文类型：期刊论文

【摘要】：正随着全球步入老龄化社会,脑梗死患病率不断增加,心脑血管疾病已成为导致人类死亡的主要病因~([1])。阿司匹林作为抗血小板聚集药物,可以降低缺血性卒中的风险,是卒中一级预防及二级预防的基石~([2])。随着阿司匹林临床应用的扩展,研究发现,阿司匹林在人群中存在个体差异,5.5%~61%的卒中患者对阿司匹林的抗血小板聚集治疗不敏感,即为阿司匹林抵抗~([3])。目前阿司匹林抵抗发生的机制尚不清楚,潜在因素包括患者的顺应性、临床特征、
[Abstract]:As the world enters an aging society, the prevalence of cerebral infarction is increasing. Cardiovascular and cerebrovascular diseases have become the main cause of human death (. [1. Aspirin, as an antiplatelet aggregation drug, can reduce the risk of ischemic stroke and is the cornerstone of primary and secondary prevention of stroke (. [2. With the expansion of clinical application of aspirin, the study found that there were individual differences in aspirin in the population of 5.5% of stroke patients were not sensitive to the antiplatelet aggregation therapy of aspirin. That is aspirin resistance (. [3. At present, the mechanism of aspirin resistance is not clear, the potential factors include patient compliance, clinical characteristics,
【作者单位】：中国医科大学附属盛京医院神经内科;
【分类号】：R743.3
【正文快照】： 作者单位:110004沈阳,中国医科大学附属盛京医院神经内科随着全球步入老龄化社会,脑梗死患病率不断增加,心脑血管疾病已成为导致人类死亡的主要病因[1]。阿司匹林作为抗血小板聚集药物,可以降低缺血性卒中的风险,是卒中一级预防及二级预防的基石[2]。随着阿司匹林临床应用的扩

【相似文献】